(Washington, D.C.) – The U.S. Department of Housing and Urban Development (HUD), White House Office of National Drug Control Policy (ONDCP), and the U.S. Department of Health and Human Services (HHS) issued a joint letter to public health departments and health care systems to partner with housing providers, community development organizations, and other housing agencies to help expand access to naloxone and other life-saving overdose reversal medications in the communities they serve.
The FDA approved certain naloxone nasal sprays for non-prescription, over-the-counter use in March and July of this year. Now, for the first time ever, naloxone is available for over-the-counter purchase at grocery stores and pharmacies across the country. Other opioid overdose reversal medications are available with a prescription and may be covered by health insurers.
